关于推荐2015年度中国药学发展奖创新药物奖候选人的通知

发布时间：2018-03-08 13:00

  本文选题：中国药学发展奖　切入点：创新药物　出处：《中国药学杂志》2015年04期 　论文类型：期刊论文

【摘要】：正中国药学发展奖是国家科技部首批批准设立的奖励科技人物的全国医药学奖项,是为促进我国药学事业发展、鼓励自主创新、攀登科学技术高峰、激励药物创新研究、技术开发、成果商品化和产业化、赶超世界先进水平而设立。2015年度中国药学发展奖创新药物奖由中国药学会和中国药学发展奖奖励工作委员会联合主办。中国药学发展奖现已举办了12届,被推荐候选人达678人,获奖专家总人数192人,其中院士16人,他们是:嵇汝运、肖培根、唐希灿、刘耕陶、侯云德、黄翠芬、徐国钧、李连达、陈志南、谢毓元、池志强、戴\戎、于德泉、金国章、张生勇、王广基等院士。每届颁奖大会,中央电视台、新华社及三大医药报刊、科技日报、网络媒体及时跟
[Abstract]:The China Pharmaceutical Development Award is the first national medicine award approved by the Ministry of Science and Technology to reward scientific and technological figures. It is designed to promote the development of the pharmaceutical industry in China, encourage independent innovation, climb the peak of science and technology, and stimulate the research of drug innovation. Technology development, commercialization and industrialization of achievements, The China Pharmaceutical Development Award of the year 2015 was jointly sponsored by the China Pharmaceutical Society and the China Pharmaceutical Development Award Award work Committee. The China Pharmaceutical Development Award has now held 12 sessions, with 678 recommended candidates. The total number of award-winning experts is 192, of whom 16 are academicians. They are Ji Ruyun, Xiao Peigen, Tang Xican, Liu Gengtao, Liu Gengtao, Liu Gengtao, #china_person鈪，

本文编号：1583996